NeRRe Therapeutics Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Stevenage United Kingdom (2012)
Status: Acquired by Bayer (2020)

Organization Overview

First Clinical Trial
2016
NCT02865538
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Nerre Therapeutics Ltd.